Decoding China's Marketing Authorization Holder (MAH) System

The webinar was successfully concluded on

March 06, 2024

Topics Covered:

Introduction to the Chinese MAH System.
MAH Legislative History.
Administration Structure.
Overview of MAH Responsibilities.
Marketing Authorization Application.
Pharmaceutical Product Import.
Pharmaceutical Product Distribution.
Agent of Overseas MAH.
The Challenges & Benefits of Appointing MAH Agent in China.
Tips for Navigating the MAH Agent Landscape in China.
Q&A Session.

As a continuous practice, Freyr organizes more webinar sessions related to Regulatory aspects in Life Sciences. We presume you would like to be a part of all those sessions. If so, let us have an opportunity to inform you about our next session.

Patricia is a Regulatory Affairs (RA) expert with over thirty (30+) years of experience in the Japanese market. As the Head of Country for Freyr Life Sciences Japan, she leads a team of over twenty (20+) Subject Matter Experts (SMEs) who assist international clients in obtaining Regulatory approval in Japan.

Jane has over seventeen (17+) years of experience in new drug R&D and more than twenty (20+) years in Regulatory Affairs (RA). She possesses a deep understanding of NMPA and global regulations, including FDA, EU, and ICH. Her strong scientific background, extensive knowledge, and previous role as a CDE reviewer contribute to her comprehensive understanding and interpretation of these regulations.

Hosted By

Patricia Bader – Johnston

Representative Director & Country Head, Freyr Japan

Presented By

Jane Zhang

Sr. Director Regulatory Affairs, Freyr China

Creating compliant packaging for a cosmetic product is a collaborative effort of various departments in an organization such as: Labeling, Artwork and Regulatory Affairs. While label artwork must be validated by an artwork labeling team, it must combinedly be reviewed and approved by Regulatory Affairs team to ensure the compliance.

Artwork services for the current Consumer Healthcare/Food Supplements landscapes are divided as per the markets. For Compliance based markets, artworks are created by Freyr team and submitted to the client for finalizing the artwork/ label.

The current medical device landscape has turned challenging for manufacturers in terms of ensuring quality and audit compliance due to ever-evolving regulations which may lead to extended time for approvals and market access.